Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Kathryn Roberts, PhD |
Young Investigator Grants |
2013 |
Tennessee |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma |
Dana-Farber Cancer Institute / Riaz Gillani, MD |
Young Investigator Grants |
2021 |
Massachusetts |
Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
Micro-environmental Regulators of Ewing sarcoma Metastasis |
University of Pittsburgh / Kelly Bailey, MD/PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells |
University of California Berkeley / Erin Simonds, PhD |
Young Investigator Grants |
2013 |
California |
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus / Catherine Danis, PhD |
Young Investigator Grants |
2023 |
Colorado |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |